Literature DB >> 1378316

Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.

A M Turner1, K M Zsebo, F Martin, F W Jacobsen, L G Bennett, V C Broudy.   

Abstract

Human stem cell factor (SCF) acts in the presence of other growth factors to stimulate the growth of primitive hematopoietic progenitor cells. These effects are performed by activation of the SCF receptor, c-kit. Because of the potential use of SCF in patients undergoing chemotherapy and bone marrow transplantation, the effect of SCF on nonhematopoietic tumors requires investigation. To determine whether human tumor cell lines display c-kit receptors, we performed binding experiments with 125I-SCF on a breast carcinoma cell line (Du4475), a gastric carcinoma cell line (KATO III), a melanoma cell line (HTT144), as well as two small cell lung carcinoma cell lines (H69 and H128). The biologic effect of SCF on tumor cell lines was assessed by its ability to stimulate tritiated thymidine uptake and to enhance colony growth in methylcellulose. The breast carcinoma cell line, Du4475, as well as two small cell lung carcinoma cell lines, H69 and H128, exhibit high-affinity c-kit receptors with approximate binding affinities of 40, 100, and 90 pmol/L, respectively. The number of high-affinity receptors per cell ranged from 700 to 9,500. The gastric carcinoma cell line, as well as the melanoma cell line, showed trace binding of 125I-SCF. In the presence of SCF alone, or in combination with granulocyte-macrophage colony-stimulating factor or interleukin-3, there was less than a 17% increase in the colony growth of Du4475, H69, or H128 cell lines. Postulating that the lack of growth response could be secondary to endogenous SCF production by the tumor cell lines, we used an RNAse protection assay to determine whether the tumor cell lines contain SCF messenger RNA (mRNA). In addition, we tested tumor cell line supernatants for the presence of secreted SCF protein by enzyme immunoassay, and analyzed the tumor cell lines for membrane-bound SCF by indirect immunofluorescence. Our results show that the Du4475, H69, and H128 cell lines, as well as a melanoma cell line (HTT144), have multiple copies of SCF mRNA. Soluble SCF protein was detected in the cell supernatants in the Du4475 and H69 cell lines and SCF was found on the surface of all four cell lines. These data show that some human solid tumor cell lines display high-affinity c-kit receptors and produce SCF, which can be detected on the cell surface. These results suggest the possibility that autocrine production of SCF by c-kit receptor-bearing tumor cells may enhance cell growth in tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378316

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.

Authors:  Robert J Coffey; Mary Kay Washington; Christopher L Corless; Michael C Heinrich
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.

Authors:  L Landuzzi; C De Giovanni; G Nicoletti; I Rossi; C Ricci; A Astolfi; L Scopece; K Scotlandi; M Serra; G P Bagnara; P Nanni; P L Lollini
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.

Authors:  A Juurikivi; C Sandler; K A Lindstedt; P T Kovanen; T Juutilainen; M J Leskinen; T Mäki; K K Eklund
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

Review 4.  Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options.

Authors:  Veronica Veschi; Francesco Verona; Carol J Thiele
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-19       Impact factor: 5.555

5.  Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression.

Authors:  S Safarians; S P Rivera; M D Sternlicht; F Naeim; S H Barsky
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Poorly differentiated carcinoma of the rectum with aberrant immunophenotype: a case report.

Authors:  A Giannopoulos; I Papaconstantinou; P Alexandrou; A Petrou; A Papalambros; E Felekouras; E Papalambros
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Authors:  Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus Früh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.

Authors:  Youzhi Xu; Hongjun Lin; Nana Meng; Wenjie Lu; Guobo Li; Yuanyuan Han; Xiaoyun Dai; Yong Xia; Xiangrong Song; Shengyong Yang; Yuquan Wei; Luoting Yu; Yinglan Zhao
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Stem cell factor and its receptor, c-kit, are important for hepatocyte proliferation in wild-type and tumor necrosis factor receptor-1 knockout mice after 70% hepatectomy.

Authors:  Xiaodan Ren; Bin Hu; Lisa Colletti
Journal:  Surgery       Date:  2008-06       Impact factor: 3.982

10.  Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.

Authors:  C Bokemeyer; M A Kuczyk; T Dunn; J Serth; K Hartmann; J Jonasson; T Pietsch; U Jonas; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.